| Biosimilars and Bioanalytical Methods | Lifetime | 9 | US 1 | 99.65 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 29 | US 8 | 99.82 |
| Systemic Lupus Erythematosus Research | Lifetime | 52 | US 17 | 99.70 |
| Autoimmune and Inflammatory Disorders Research | Lifetime | 26 | US 9 | 99.69 |
| Chronic Lymphocytic Leukemia Research | Lifetime | 146 | US 82 | 99.53 |
| Hip and Femur Fractures | Lifetime | 68 | US 31 | 99.52 |
| Bone health and osteoporosis research | Lifetime | 109 | US 53 | 99.36 |
| Bone and Joint Diseases | Lifetime | 125 | US 54 | 98.87 |
| Lymphoma Diagnosis and Treatment | Lifetime | 385 | US 190 | 98.97 |
| Bone health and treatments | Lifetime | 283 | US 137 | 98.57 |
| Herpesvirus Infections and Treatments | Lifetime | 392 | US 250 | 97.94 |
| Spondyloarthritis Studies and Treatments | Lifetime | 196 | US 45 | 97.90 |
| Medication Adherence and Compliance | Lifetime | 223 | US 138 | 96.54 |
| Psoriasis: Treatment and Pathogenesis | Lifetime | 451 | US 125 | 96.58 |
| Viral Infections and Immunology Research | Lifetime | 941 | US 387 | 95.92 |
| Pregnancy and Medication Impact | Lifetime | 604 | US 240 | 94.47 |
| Peripheral Neuropathies and Disorders | Lifetime | 994 | US 271 | 93.50 |
| Adrenal Hormones and Disorders | Lifetime | 944 | US 337 | 92.11 |
| Drug-Induced Adverse Reactions | Lifetime | 974 | US 295 | 90.42 |
| Intramuscular injections and effects | Lifetime | 198 | US 77 | 86.03 |
| Case Reports on Hematomas | Lifetime | 405 | US 144 | 81.12 |
| Medical Coding and Health Information | Lifetime | 620 | US 234 | 74.04 |
| Rheumatoid Arthritis Research and Therapies | 2021-2025 | 11 | US 3 | 99.72 |
| Autoimmune and Inflammatory Disorders Research | 2021-2025 | 9 | US 3 | 99.60 |
| Systemic Lupus Erythematosus Research | 2021-2025 | 24 | US 9 | 99.24 |
| Herpesvirus Infections and Treatments | 2021-2025 | 30 | US 16 | 97.52 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 696 | US 219 | 97.25 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 64 | US 23 | 95.78 |
| Chronic Lymphocytic Leukemia Research | 2021-2025 | 241 | US 111 | 97.23 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 96 | US 17 | 97.00 |
| Psoriasis: Treatment and Pathogenesis | 2021-2025 | 417 | US 71 | 90.79 |
| Vasculitis and related conditions | 2021-2025 | 432 | US 70 | 86.93 |
| Intramuscular injections and effects | 2021-2025 | 55 | US 8 | 78.70 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 881 | US 197 | 72.02 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 302 | US 96 | 67.31 |
| Otitis Media and Relapsing Polychondritis | 2021-2025 | 997 | US 148 | 47.52 |
